Extractables & Leachables (E&L) Testing

Extractables & Leachables (E&L) Testing

Product

Information

Container closure systems, drug delivery devices, and packaging materials can introduce potentially harmful chemical entities into drug products — making Extractables and Leachables (E&L) testing a critical component of pharmaceutical safety and regulatory compliance. ResolveMass Laboratories offers advanced mass spectrometry-based E&L studies that meet the evolving expectations of FDA, EMA, USP, and ISO standards, including USP <1664> and ISO 10993 frameworks. Our extractables studies employ a broad battery of analytical techniques — including GC-MS, LC-MS/MS, ICP-MS, and headspace analysis — to comprehensively identify and quantify chemical entities that may migrate from materials under controlled extraction conditions. We apply both targeted and ...
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Supplied From
Canada
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Biopharmaceutical ServicesContract Research Organisations (CROs) (Services)
All Categories
Analytical Chemistry (Biopharmaceutical Services)Analytical Methods (Biopharmaceutical Services)Medicinal Chemistry (Biopharmaceutical Services)Protein Chemistry (Biopharmaceutical Services)Analytical DevelopmentDevelopment & Validation of Analytical MethodsBio Analytical ServicesLeachables/Extractables/Particulates

Log in

See all the content and easy-to-use features by logging in or registering!